Palmitoylethanolamide and luteolin vs no intervention
Change in sense of smell · adults with olfactory dysfunction for ≥ 4 weeks following COVID‐19 infection
1 finding from 1 review
- Interventions for the treatment of persistent post‐COVID‐19 olfactory dysfunction 2022 · Cochrane Headline outcomes onlyno estimate extracted1 study · 12 participantsVery low